195
Views
4
CrossRef citations to date
0
Altmetric
Articles

Molecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIs

, , , , , , , & show all
Pages 697-714 | Received 05 Jul 2019, Accepted 05 Aug 2019, Published online: 23 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

M. Haroun, A. Petrou, C. Tratrat, K. Kositsi, A. Gavalas, A. Geronikaki, K.N. Venugopala & N. Sreeharsha. (2022) Discovery of benzothiazole-based thiazolidinones as potential anti-inflammatory agents: anti-inflammatory activity, soybean lipoxygenase inhibition effect and molecular docking studies. SAR and QSAR in Environmental Research 33:6, pages 485-497.
Read now
M. Merlani, V. Barbakadze, L. Amiranashvili, L. Gogilashvili, A. Petrou, A. Geronikaki, A. Ćirić, J. Glamočlija & M. Soković. (2022) Caffeic and 3-(3,4-dihydroxyphenyl)glyceric acid derivatives as antimicrobial agent: biological evaluation and molecular docking studies. SAR and QSAR in Environmental Research 33:4, pages 307-321.
Read now

Articles from other publishers (2)

Rahul Singh, Parvin Kumar, Jayant Sindhu, Meena Devi, Ashwani Kumar, Sohan Lal & Devender Singh. (2023) Parsing structural fragments of thiazolidin-4-one based α-amylase inhibitors: A combined approach employing in vitro colorimetric screening and GA-MLR based QSAR modelling supported by molecular docking, molecular dynamics simulation and ADMET studies. Computers in Biology and Medicine 157, pages 106776.
Crossref
Christophe Tratrat, Anthi Petrou, Athina Geronikaki, Marija Ivanov, Marina Kostić, Marina Soković, Ioannis S. Vizirianakis, Nikoleta F. Theodoroula & Michelyne Haroun. (2022) Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation. Molecules 27:6, pages 1930.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.